{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:03:58Z","timestamp":1793034238739,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Vitiligo is a challenging chronic condition with unpredictable disease course and high propensity for relapse post-treatment. Recent studies have reported the biomarkers for disease activity, severity, and therapeutic response of vitiligo, yet very few have investigated cytokines as predictive biomarkers for disease recurrence in vitiligo. This study aims to explore cytokines that serve as biomarkers for disease recurrence and extend research on factors related to the disease\u2019s activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>92 patients and 40 healthy controls were recruited at the Air Force Medical Center from September 20, 2023, to November 30, 2023. Ultrasensitive multiplex cytokine array was used to measure plasma concentrations of cytokines, including IFN-\u03b3, CXCL9, CXCL10, CXCL11, IL-6, and IL-15.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IFN-\u03b3, CXCL9, CXCL10, CXCL11, IL-6, and IL-15 were expressed at higher levels in the circulation of patients with both segmental and non-segmental vitiligo compared to healthy controls (p &amp;lt; 0.001). There were no significant differences in these cytokine levels between the two types of vitiligo. CXCL9 was associated with the activity of vitiligo (p = 0.027). Correlation analysis showed a positive relationship between IFN-\u03b3, CXCL9, CXCL10, CXCL11, IL-6, and IL-15 in the plasma of patients with recurrent vitiligo. The expression of IFN-\u03b3, CXCL9, CXCL10, CXCL11, and IL-6 was significantly higher in recurrent vitiligo than in cases of persistent stable vitiligo (p = 0.001, p = 0.003, p &amp;lt; 0.001, p = 0.002, p = 0.026, respectively), with ROC analysis demonstrating their predictive capability for vitiligo recurrence, with AUC values of 0.806, 0.773, 0.896, 0.785, and 0.709, respectively. Multivariate logistic regression model showed IFN-\u03b3 is an independent predictor for vitiligo recurrence [OR (95%CI) =1.051 (1.012~1.116)], with a prediction accuracy of 90.5% (38\/42) on the training dataset and 88.9% (16\/18) on the testing dataset.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma IFN-\u03b3, CXCL9, CXCL10, CXCL11 and IL-6 might be potential biomarkers for vitiligo recurrence, with CXCL9 also associated with disease activity. Additionally, multivariate logistic regression model demonstrated that IFN-\u03b3 is an independent predictor of vitiligo recurrence and the model could be a candidate approach for predicting vitiligo recurrence.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1468665","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:11:04Z","timestamp":1738825864000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers"],"prefix":"10.3389","volume":"16","author":[{"given":"Binhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0804388","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12878","article-title":"The enigma and challenges of vitiligo pathophysiology and treatment","volume":"33","author":"Abdel-Malek","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000506103","article-title":"Vitiligo: A review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.568447","article-title":"Autoimmunity in segmental vitiligo","volume":"11","author":"Speeckaert","year":"2020","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol (1951)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/01.lab.0000069521.42488.1b","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.073","article-title":"Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)","volume":"74","author":"Harris","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfx083","article-title":"From the cover: interplay between IFN-\u03b3 and IL-6 impacts the inflammatory response and expression of interferon-regulated genes in environmental-induced autoimmunity","volume":"158","author":"Cauvi","year":"2017","journal-title":"Toxicol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1172\/JCI17129","article-title":"Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation","volume":"112","author":"McLoughlin","year":"2003","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04221-8","article-title":"Anatomically distinct fibroblast subsets determine skin autoimmune patterns","volume":"601","author":"Xu","year":"2022","journal-title":"Nat (London)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"18298","DOI":"10.1038\/s41598-021-97296-2","article-title":"CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.032","article-title":"Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo","volume":"139","author":"Richmond","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15016","article-title":"The role of interleukins in vitiligo: a systematic review","volume":"32","author":"Gomes","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872458","article-title":"Skin interstitial fluid and plasma multiplex cytokine analysis reveals IFN-\u03b3 Signatures and granzyme B as useful biomarker for activity, severity and prognosis assessment in vitiligo","volume":"13","author":"Ng","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4483","article-title":"Association of clinical markers with disease progression in patients with vitiligo from China","volume":"156","author":"Zhang","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0485","article-title":"Increase of interferon-\u03b3 Inducible CXCL9 and CXCL11 serum levels in patients with active graves\u2019 Disease and modulation by methimazole therapy","volume":"23","author":"Antonelli","year":"2013","journal-title":"Thyroid"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155353","article-title":"Serum interferon levels associated with the disease activity in women with overt Graves\u2019 disease","volume":"138","author":"Cheng","year":"2021","journal-title":"Cytokine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5401","article-title":"Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves\u2019 disease, and modulation by methimazole therapy and thyroidectomy","volume":"93","author":"Antonelli","year":"2006","journal-title":"Br J Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201586","article-title":"IFN\u03b1 and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus","volume":"72","author":"Rose","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.17","article-title":"Increased expression of cxcr3 and its ligands, cxcl9 and cxcl10, during the development of alopecia areata in the mouse","volume":"132","author":"McPhee","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13283","article-title":"Serum cytokines to predict systemic lupus erythematosus clinical and serological activity","volume":"15","author":"Moreno-Torres","year":"2022","journal-title":"Clin Transl Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2011.06.033","article-title":"Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array","volume":"372","author":"Dabitao","year":"2011","journal-title":"J Immunol Methods"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02228-9","article-title":"Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome","volume":"314","author":"El-Domyati","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2019.31.4.393","article-title":"Increased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areata","volume":"31","author":"Zhang","year":"2019","journal-title":"Ann Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185861","article-title":"Serum inflammatory and oxidative stress markers in patients with vitiligo","volume":"12","author":"Kassab","year":"2023","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112811","article-title":"A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes","volume":"14","author":"Speeckaert","year":"2023","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2018.12.001","article-title":"Alopecia areata: A multifactorial autoimmune condition","volume":"98","author":"Simakou","year":"2019","journal-title":"J Autoimmun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12667","article-title":"CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study","volume":"31","author":"Abdallah","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.abd.2023.03.007","article-title":"Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers","volume":"99","author":"Mascarenhas","year":"2024","journal-title":"Bras Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417306","article-title":"Vitiligo: pathogenesis and new and emerging treatments","volume":"24","author":"Perez-Bootello","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00524-0","article-title":"Vitiligo and melanoma-associated vitiligo: understanding their similarities and differences","volume":"21","author":"Cohen","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of immune-related adverse events and kinetics of response with ipilimumab","volume":"30","author":"Weber","year":"2012","journal-title":"J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91190","article-title":"IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved interferon-\u03b3 Signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8 + T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8(+) T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.04.027","article-title":"Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells","volume":"141","author":"Azzolino","year":"2021","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1468665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:11:08Z","timestamp":1738825868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1468665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2025.1468665"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1468665","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1468665"}}